OLD Category: pan cancer panels
May 7, 2018 / Cell
Interfaces of Malignant and Immunologic Clonal Dynamics in Ovarian Cancer
April 30, 2018 / Clin. Can. Res,
Novel effector phenotype of Tim-3+ regulatory T cells leads to enhanced suppressive function in head and neck cancer patients
April 24, 2018 / Oncotarget
The critical role that STAT3 plays in glioma-initiating cells: STAT3 addiction in glioma
March 28, 2018 / Front. Mol. Neurosci.
The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
March 28, 2018 / Mol. Cancer. Ther.
Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition
March 8, 2018 / Mol. Can. Res.
Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
March 5, 2018 / JCI
PD-L1 in tumor microenvironment mediates resistance to oncolytic immunotherapy
January 30, 2018 / Breast Can. Res.
HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors
January 25, 2018 / Mol. Therapy